Boothbay Fund Management, LLC Biogen Inc. Transaction History

Boothbay Fund Management, LLC

$3.37 Billion
Q2 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $271,877 - $330,337	-1,077 Reduced 55.89%	850 $235,000
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $3.55 Million - $4.89 Million	-18,225 Reduced 90.44%	1,927 $515,000
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $375 - $446	2 Added 0.01%	20,152 $4.11 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $623,358 - $785,398	-3,217 Reduced 13.77%	20,150 $4.24 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $2.93 Million - $3.76 Million	13,079 Added 127.13%	23,367 $5.61 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $2.61 Million - $3.41 Million	-9,233 Reduced 47.3%	10,288 $2.91 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $4.59 Million - $7.36 Million	17,741 Added 996.69%	19,521 $6.76 Million
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $170,065 - $199,241	-700 Reduced 28.23%	1,780 $498,000
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $314,934 - $474,054	1,333 Added 116.22%	2,480 $607,000
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $1.1 Million - $1.27 Million	-4,166 Reduced 78.41%	1,147 $325,000
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $234,345 - $310,350	-906 Reduced 14.57%	5,313 $1.42 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $209,971 - $266,352	-781 Reduced 11.16%	6,219 $1.97 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $238,765 - $329,915	-1,085 Reduced 13.42%	7,000 $2.08 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $190,694 - $213,882	877 Added 12.17%	8,085 $1.88 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $1.68 Million - $1.86 Million	-7,679 Reduced 51.58%	7,208 $1.69 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $3.23 Million - $5.05 Million	14,887 New	14,887 $3.52 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Account